Literature DB >> 18668617

Deep brain stimulation effect on freezing of gait.

Murielle U Ferraye1, Bettina Debû, Pierre Pollak.   

Abstract

The majority of patients with Parkinson's disease suffer from freezing of gait (FOG), which responds more or less to levodopa. Thalamic stimulation, mainly used in the treatment of tremor dominant Parkinson's disease is ineffective in FOG. GPi stimulation moderately improves FOG, but this effect may abate in the long term. STN stimulation was reported to improve levodopa-responsive FOG. In some patients, the benefit from levodopa is greater than that from STN stimulation, and levodopa and STN stimulation can have additive effects. On the contrary, STN stimulation is ineffective on levodopa-resistant FOG. In the few cases of levodopa-induced FOG, STN stimulation can indirectly be effective, thanks to a great decrease or arrest of levodopa. Stimulation of the pedunculopontine nucleus has recently been performed in small groups of patients suffering from both off- and on-levodopa gait impairments. The first results appear encouraging, but they need to be confirmed by controlled studies in larger series of patients. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18668617     DOI: 10.1002/mds.21975

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  Managing Gait, Balance, and Posture in Parkinson's Disease.

Authors:  Bettina Debû; Clecio De Oliveira Godeiro; Jarbas Correa Lino; Elena Moro
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-06       Impact factor: 5.081

2.  Identifying the neural correlates of doorway freezing in Parkinson's disease.

Authors:  Elie Matar; James M Shine; Moran Gilat; Kaylena A Ehgoetz Martens; Philip B Ward; Michael J Frank; Ahmed A Moustafa; Sharon L Naismith; Simon J G Lewis
Journal:  Hum Brain Mapp       Date:  2019-01-13       Impact factor: 5.038

3.  Non-human primate FOG develops with advanced parkinsonism induced by MPTP Treatment.

Authors:  Gonzalo J Revuelta; Subramaniam Uthayathas; Amy E Wahlquist; Stewart A Factor; Stella M Papa
Journal:  Exp Neurol       Date:  2012-08-07       Impact factor: 5.330

Review 4.  Treadmill training for the treatment of gait disturbances in people with Parkinson's disease: a mini-review.

Authors:  T Herman; N Giladi; J M Hausdorff
Journal:  J Neural Transm (Vienna)       Date:  2008-11-04       Impact factor: 3.575

Review 5.  Spinal cord stimulation for Parkinson's disease: a systematic review.

Authors:  Emerson Magno de Andrade; Maria Gabriela Ghilardi; Rubens Gisbert Cury; Egberto Reis Barbosa; Romulo Fuentes; Manoel Jacobsen Teixeira; Erich Talamoni Fonoff
Journal:  Neurosurg Rev       Date:  2015-07-30       Impact factor: 3.042

6.  [Freezing of gait : phenomenology, pathophysiology, and therapeutic approaches].

Authors:  F Schroeteler; K Ziegler; U M Fietzek; A Ceballos-Baumann
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 7.  Therapy-resistant symptoms in Parkinson's disease.

Authors:  Ruxandra Julia Vorovenci; Roberta Biundo; Angelo Antonini
Journal:  J Neural Transm (Vienna)       Date:  2015-09-26       Impact factor: 3.575

Review 8.  Pedunculopontine Nucleus Deep Brain Stimulation Improves Gait Disorder in Parkinson's Disease: A Systematic Review and Meta-analysis.

Authors:  Fabin Lin; Dihang Wu; Chenxin Lin; Huihui Cai; Lina Chen; Guofa Cai; Qinyong Ye; Guoen Cai
Journal:  Neurochem Res       Date:  2020-01-16       Impact factor: 3.996

9.  Neural closed-loop deep brain stimulation for freezing of gait.

Authors:  Matthew N Petrucci; Raumin S Neuville; M Furqan Afzal; Anca Velisar; Chioma M Anidi; Ross W Anderson; Jordan E Parker; Johanna J O'Day; Kevin B Wilkins; Helen M Bronte-Stewart
Journal:  Brain Stimul       Date:  2020-07-04       Impact factor: 8.955

Review 10.  Freezing of gait and fall detection in Parkinson's disease using wearable sensors: a systematic review.

Authors:  Ana Lígia Silva de Lima; Luc J W Evers; Tim Hahn; Lauren Bataille; Jamie L Hamilton; Max A Little; Yasuyuki Okuma; Bastiaan R Bloem; Marjan J Faber
Journal:  J Neurol       Date:  2017-03-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.